Ramona Scherrer
Overview
Explore the profile of Ramona Scherrer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
1224
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scherrer R, Tschumi N, Lejone T, Kopo M, Motaboli L, Mothobi B, et al.
Pilot Feasibility Stud
. 2022 Mar;
8(1):61.
PMID: 35277206
Background: Multi-month dispensing (MMD) of antiretroviral therapy (ART) represents one approach of differentiated service delivery (DSD) aiming to improve quality and cost-effectiveness for HIV services in resource-limited settings. However, reduction...
2.
Scheidmann M, Castro-Giner F, Strittmatter K, Krol I, Paasinen-Sohns A, Scherrer R, et al.
Cancer Res
. 2021 Dec;
82(4):681-694.
PMID: 34916221
Significance: A loss-of-function CRISPR screen in human CTC-derived xenografts identifies genes critical for individual steps of the metastatic cascade, suggesting novel drivers and treatment opportunities for metastatic breast cancers.
3.
Donato C, Kunz L, Castro-Giner F, Paasinen-Sohns A, Strittmatter K, Szczerba B, et al.
Cell Rep
. 2020 Sep;
32(10):108105.
PMID: 32905777
Circulating tumor cells (CTCs) are shed from solid cancers in the form of single or clustered cells, and the latter display an extraordinary ability to initiate metastasis. Yet, the biological...
4.
Lejone T, Kopo M, Bachmann N, Brown J, Glass T, Muhairwe J, et al.
BMC Public Health
. 2020 Apr;
20(1):425.
PMID: 32228531
Background: Despite tremendous progress in controlling the HIV epidemic in sub-Saharan Africa, HIV-related mortality continues to increase among adolescents and young people living with HIV (AYPLHIV). Globally, sub-Saharan Africa accounts...
5.
Szczerba B, Castro-Giner F, Vetter M, Krol I, Gkountela S, Landin J, et al.
Nature
. 2019 Feb;
566(7745):553-557.
PMID: 30728496
A better understanding of the features that define the interaction between cancer cells and immune cells is important for the development of new cancer therapies. However, focus is often given...
6.
Gkountela S, Castro-Giner F, Szczerba B, Vetter M, Landin J, Scherrer R, et al.
Cell
. 2019 Jan;
176(1-2):98-112.e14.
PMID: 30633912
The ability of circulating tumor cells (CTCs) to form clusters has been linked to increased metastatic potential. Yet biological features and vulnerabilities of CTC clusters remain largely unknown. Here, we...
7.
Vetter M, Landin J, Szczerba B, Castro-Giner F, Gkountela S, Donato C, et al.
Breast Cancer Res
. 2018 Nov;
20(1):141.
PMID: 30458879
Background: The presence of circulating tumor cells (CTCs) in patients with breast cancer correlates to a bad prognosis. Yet, CTCs are detectable in only a minority of patients with progressive...
8.
Krol I, Castro-Giner F, Maurer M, Gkountela S, Szczerba B, Scherrer R, et al.
Br J Cancer
. 2018 Aug;
119(4):487-491.
PMID: 30065256
Human glioblastoma (GBM) is a highly aggressive, invasive and hypervascularised malignant brain cancer. Individual circulating tumour cells (CTCs) are sporadically found in GBM patients, yet it is unclear whether multicellular...